Videos

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss the benefits of attending NASP during the NASP Annual Meeting in Washington, DC.

Jesse C. Dresser, Esq explains the current climate of PBM reform at the NASP Annual Meeting in Washington, DC.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss the goals and importance of his company, Stack, during the NASP Annual Meeting in Washington, DC.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how vertical integration might affect biosimilar availability in specialty pharmacy during the NASP Annual Meeting in Washington, DC.

Amina Abubakar, PharmD, AAHIVP, discusses the current regulatory system around pharmacogenomics. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Jesse C. Dresser, Esq explains how DIR fees affect specialty pharmacists at the NASP Annual Meeting in Washington, DC.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how specialty pharmacists can show their value during the NASP Annual Meeting in Washington, DC.

Jesse C. Dresser, Esq explains a recent piece of PBM legislation from North Dakota and its implications for specialty pharmacy at the NASP Annual Meeting in Washington, DC.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Amina Abubakar, PharmD, AAHIVP, discusses how pharmacogenomics works in her daily practice with patients. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss why data standardization is important in specialty pharmacy and how technology plays into it during the NASP Annual Meeting in Washington, DC.

Calvin Knowlton, BSc Pharm, MDiv, PhD, and CEO, Chairman, & Founder of Tabula Rasa Healthcare, discusses his model for the 'concierge pharmacist' and what it means for pharmacy profits. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Adam Martin, PharmD and founder of The Fit Pharmacist, discusses techniques for managing stress as a pharmacist.

Ken Whittemore, VP of professional & regulatory affairs for SureScripts, discusses how SCRIPT standards began. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

"Has this ever happened to you? After you try to contact the patient’s doctor 3 times for refills and the office still has not responded and you tell the patient that she should try calling, she responds, 'Well, that is your job!'”

Jesica Mills, PharmD, MBA, discusses the opportunities pharmacists have to help their patients with hemp-derived CBD products. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Jesse C. Dresser, Esq explains how specialty pharmacists can educate and inform legislators on PBM reform at the NASP Annual Meeting in Washington, DC.

Introducing Adam Martin, PharmD, founder of The Fit Pharmacist.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Kala Shankle, JD, and Lisa Schwartz, PharmD, RPh, discuss the DSCSA and what it means for pharmacists. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Karla Palmer, director at Hyman, Phelps, & McNamara, discusses how the Hemp Farming Act of 2018 affected hemp and CBD products.

Calvin Knowlton, BSc Pharm, MDiv, PhD, and CEO, Chairman, & Founder of Tabula Rasa Healthcare, discusses how pharmacists should approach adverse drug events and reactions to better help their patients.

Ron Lanton III, Esq., discusses the specialty pharmacist's role in educating patients about biosimilars and biologics.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Ron Lanton III, Esq., discusses challenges in launching biosimilars after they've been approved.